Asklepios Kliniken

Asklepios Group: Positive development continued in the first half of 2024 – solid basis for further strategic development

Asklepios Group: Positive business performance in first quarter – Confident outlook for 2024

Asklepios Group: Asklepios shows resilience in 2023 financial year

Asklepios Group: Sound business performance in first nine months of 2023

Asklepios Kliniken: Stable development in H1 2023 despite challenging market environment

Asklepios Kliniken:

Asklepios Kliniken: Solid performance in 2022

Asklepios Kliniken: Group-wide ESG strategy

Asklepios Kliniken: Asklepios signs off on first-ever commercial paper program for EUR 500 million

Asklepios Kliniken: Sound business performance in first nine months of 2022

Asklepios Kliniken: Stable development continues in H1 2022

Asklepios Kliniken: Asklepios refinanziert sich frühzeitig durch Platzierung eines neuen Schuldscheindarlehens

Asklepios Kliniken: Sound growth despite challenging environment in first quarter of 2022

Asklepios Kliniken: Stable development in 2021 financial year despite negative impact from COVID-19 pandemic

Asklepios Kliniken: Stable business performance in the first nine months of 2021

Asklepios Kliniken: Asklepios secures early refinancing of schuldschein loan agreements via exchange and increase offer

Asklepios Kliniken: Coronavirus pandemic still having an impact in H1 2021

Asklepios Kliniken: COVID-19 pandemic impacting first quarter of 2021

Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition

Asklepios Kliniken: Consolidated net operating income impacted by continuing coronavirus pandemic

Asklepios successfully issues Schuldschein loan agreement worth EUR 730 million

Asklepios Kliniken posts sound development in operating business in first half of 2020 despite coronavirus

Asklepios Kliniken: Asklepios successfully acquires RHÖN-KLINIKUM AG

Asklepios Kliniken: Asklepios attains 83% of the voting rights in RHÖN

Asklepios Kliniken has stable start to a challenging 2020 financial year

Asklepios Kliniken: Joint venture between Asklepios and RHÖN founder Eugen Münch cleared by Bundeskartellamt

Asklepios Kliniken: Asklepios publishes 2019 consolidated financial statements

Asklepios Kliniken: COMMENCEMENT OF ACCEPTANCE PERIOD FOR PUBLIC TAKEOVER OFFER SUBMITTED BY ASKLEPIOS KLINIKEN GMBH & CO. KGAA FOR THE SHARES OF RHÖN-KLINIKUM AG

Asklepios Kliniken: Asklepios-Münch joint venture attains targeted voting rights majority in RHÖN

Asklepios and RHÖN-KLINIKUM founder join forces: Agreement on joint venture and takeover offer for RHÖN-KLINIKUM AG